Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability (2015 - 2023)
Aytu Biopharma (AYTU) posted quarterly Non-Current Deferred Tax Liability of $100000.0 for Q2 2023, little changed year-over-year from $100000.0 in Q2 2022, and little changed quarter-over-quarter from $100000.0 in Q2 2022.
Aytu Biopharma (AYTU) Non-Current Deferred Tax Liability (2015 - 2023) Analysis & Trends
Aytu Biopharma (AYTU) has reported Non-Current Deferred Tax Liability for 4 consecutive years, with $100000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $100000.0; the TTM figure through Jun 2023 stood at $100000.0 (changed 0.0% YoY), while the FY2023 annual figure was $100000.0, changed 0.0% from the prior year.
- Non-Current Deferred Tax Liability held at $100000.0 in Q2 2023 per AYTU's latest filing, from $100000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $200000.0 in Q2 2021 and bottomed at $100000.0 in Q3 2021.
- Historically, Non-Current Deferred Tax Liability has averaged $120000.0 across 3 years, with a median of $100000.0 in 2021.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability plunged 50.0% — and 2023, when it changed 0.0%.
- Aytu Biopharma's Non-Current Deferred Tax Liability stood at $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022, then changed by 0.0% to $100000.0 in 2023.
- Business Quant data shows AYTU's Non-Current Deferred Tax Liability at $100000.0 in Q2 2023, $100000.0 in Q2 2022, and $100000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | Aytu Biopharma | 24.70 Mn | -2.01 Mn | 7.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Dec 31, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Sep 30, 2015 | 94,211.00 |
| Sep 30, 2015 | 94,211.00 |
| Jun 30, 2015 | 41,427.00 |
| Jun 30, 2015 | 41,427.00 |